These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 36105090)
1. A comprehensive analysis and validation of cuproptosis-associated genes across cancers: Overall survival, the tumor microenvironment, stemness scores, and drug sensitivity. Liu J; Lu Y; Dai Y; Shen Y; Zeng C; Liu X; Yu H; Deng J; Lu W Front Genet; 2022; 13():939956. PubMed ID: 36105090 [No Abstract] [Full Text] [Related]
2. Regulation, genomics, and clinical characteristics of cuproptosis regulators in pan-cancer. Zhou C; Li C; Zheng Y; Huang X Front Oncol; 2022; 12():934076. PubMed ID: 36387247 [TBL] [Abstract][Full Text] [Related]
3. Identification and Validation of Cuproptosis-Related Prognostic Signature and Associated Regulatory Axis in Uterine Corpus Endometrial Carcinoma. Chen Y Front Genet; 2022; 13():912037. PubMed ID: 35937995 [No Abstract] [Full Text] [Related]
4. Cuproptosis-related genes signature and validation of differential expression and the potential targeting drugs in temporal lobe epilepsy. Yang X; Zhang X; Shen K; Wang Z; Liu G; Huang K; He Z; Li Y; Hou Z; Lv S; Zhang C; Yang H; Liu S; Ke Y Front Pharmacol; 2023; 14():1033859. PubMed ID: 37435496 [No Abstract] [Full Text] [Related]
5. Cuproptosis-Related Genes MTF1 and LIPT1 as Novel Prognostic Biomarker in Acute Myeloid Leukemia. Li Y; Kan X Biochem Genet; 2024 Apr; 62(2):1136-1159. PubMed ID: 37561332 [TBL] [Abstract][Full Text] [Related]
6. Database Mining Detected a Cuproptosis-Related Prognostic Signature and a Related Regulatory Axis in Breast Cancer. Jiang B; Zhu H; Feng W; Wan Z; Qi X; He R; Xie L; Li Y Dis Markers; 2022; 2022():9004830. PubMed ID: 36312586 [TBL] [Abstract][Full Text] [Related]
7. Expression Profiles of Cuproptosis-Related Genes Determine Distinct Subtypes of Pancreatic Ductal Adenocarcinoma. Chen Y; Zou X; Ma M; Liu Y; Wang R; Dai Z; Tashiheng Y; Yan Y; Yu X; Wang X; Liu C; Lin X; Cheng H Curr Oncol; 2023 Jan; 30(2):1648-1662. PubMed ID: 36826087 [TBL] [Abstract][Full Text] [Related]
8. Identification of cuproptosis-related genes for predicting the development of prostate cancer. Wang X; Chen X; Xu C; Zhou W; Wu D Open Med (Wars); 2023; 18(1):20230717. PubMed ID: 37711156 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of cuproptosis genes and cuproptosis-related genes as prognosis factors in esophageal squamous cell carcinoma. Wu Z; Huang Z; Zhou X; Gao C; Peng Z; Zheng X; Zhang Y; Du Z; Wu B Genomics; 2023 Nov; 115(6):110732. PubMed ID: 37866660 [TBL] [Abstract][Full Text] [Related]
10. Characterization of cuproptosis identified immune microenvironment and prognosis in acute myeloid leukemia. Luo D; Liu S; Luo J; Chen H; He Z; Gao Z; Wen Z; Liu X; Xu N Clin Transl Oncol; 2023 Aug; 25(8):2393-2407. PubMed ID: 36826709 [TBL] [Abstract][Full Text] [Related]
11. Pan-cancer profiles of the cuproptosis gene set. Liu H Am J Cancer Res; 2022; 12(8):4074-4081. PubMed ID: 36119826 [TBL] [Abstract][Full Text] [Related]
12. A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma. Bian Z; Fan R; Xie L Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627236 [TBL] [Abstract][Full Text] [Related]
13. A cuproptosis-related gene signature and associated regulatory axis in stomach adenocarcinoma based on bioinformatics analysis. Ding D; Wang D; Qin Y Medicine (Baltimore); 2023 Jul; 102(30):e34230. PubMed ID: 37505170 [TBL] [Abstract][Full Text] [Related]
14. Distinct cuproptosis patterns in hepatocellular carcinoma patients correlate with unique immune microenvironment characteristics and cell-cell communication, contributing to varied overall survival outcomes. Wang Y; Mang X; Guo X; Pu J Front Immunol; 2024; 15():1379690. PubMed ID: 38868777 [TBL] [Abstract][Full Text] [Related]
15. A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer. Jiang X; Ke J; Jia L; An X; Ma H; Li Z; Yuan W J Cancer Res Clin Oncol; 2023 Jan; 149(1):203-218. PubMed ID: 36376617 [TBL] [Abstract][Full Text] [Related]
16. Identification of 10 differentially expressed and cuproptosis-related genes in immune infiltration and prognosis of thyroid carcinoma. Yu W; Liu H; Zhang Y; Liu M; Li W; Wang L; Li D Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):89-94. PubMed ID: 38650151 [TBL] [Abstract][Full Text] [Related]
17. A novel prognostic signature of cuproptosis-related genes and the prognostic value of FDX1 in gliomas. Zhu H; Wan Q; Tan J; Ouyang H; Pan X; Li M; Zhao Y Front Genet; 2022; 13():992995. PubMed ID: 36579333 [No Abstract] [Full Text] [Related]
18. Multi-omics pan-cancer study of cuproptosis core gene Xu J; Hu Z; Cao H; Zhang H; Luo P; Zhang J; Wang X; Cheng Q; Li J Front Immunol; 2022; 13():981764. PubMed ID: 36605188 [TBL] [Abstract][Full Text] [Related]
19. Cuproptosis-related gene SERPINE1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer. Feng L; Li G; Li D; Duan G; Liu J J Cancer Res Clin Oncol; 2023 Sep; 149(12):10851-10865. PubMed ID: 37318594 [TBL] [Abstract][Full Text] [Related]
20. Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set. Liu H; Tang T Front Oncol; 2022; 12():952290. PubMed ID: 36276096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]